CURIS INC

CRISNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$9.4M

▼ 13.4% YoY

Net Income

-$7.6M

▲ 82.5% YoY

EPS

$-0.58

▲ 91.6% YoY

Cash

$5.1M

▼ 74.7% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.